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Albumin: Creatinine Ratio during long term Diabetes Mellitus in the 
Assessment of early Nephropathy in Sudanese Population  




Background: Diabetic nephropathy is one of the major causes of chronic renal failure. 
Microalbuminuria (MAU) has been recognized as an independent and reliable predictor for future 
development of overt proteinuria in diabetic patients.  
Objectives: This descriptive cross-sectional study was carried during the period of January-April 
2012, in Omdurman Teaching Hospital, to determine Microalbuminuria creatinine ratio, in long 
term Diabetic patients.  
Materials and Methods: Immunoturbidmetric method was used to asses’ microalbuminuria in 50 
cases (50%) and 50 controls (50%). Ordinary chemical method (Jaffe reaction) was used for the 
determination of creatinine for both the groups.  
Results: Microalbuminuria in Diabetic patients showed an increase when compared with the 
control group with P value 0.000. Similarly creatinine also showed an increase in diabetic patients.  
Conclusion: It was concluded and is in further affirmation of the previous studies that 
microalbuminuria should be used as an early indicator for Diabetic Nephropathy. Further studies 
with 24 hour urine sample are recommended for assessment of Microalbuminuria in long term 
Diabetic patients, provided that the patients are on a normal diet with regular treatment for diabetes. 
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iabetes mellitus is a metabolic 
disorder characterized by chronic 
hyperglycemia due to derangement in 
carbohydrate, fat and protein metabolism that 
are associated with absolute or relative 
deficiencies in insulin secretion, insulin action 
or both1,2. Over 170 million people worldwide 
and about 2.6% of the Sudanese population 
are affected3.  
Different statistics have led to diabetes being 
described as one of the main threat to human 
health in the 21st century4. DM is the major 
cause of renal morbidity and mortality, and 
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diabetic nephropathy is one of the reasons for 
chronic kidney failure5. Non-nephritic 
protienuria, nephrotic syndrome and chronic 
renal failure are the most common lesions 
involving the glomeruli6.   Diabetes 
nephropathy is the kidney disease that occurs 
as a result of diabetes. After many years of 
diabetes the delicate filtering system in the 
kidney becomes destroyed, initially becoming 
leaky to larger blood 
 proteins such as albumin which are then lost 
in urine. This is more likely to occur if the 
blood sugar is poorly controlled7. The 
recommended albumin (μg)/creatinine (mg) 
ratio (ACR) (30 μg/mg) to detect 
microalbuminuria does not account for sex or 
racial differences in creatinine excretion. In a 
nationally representative sample of subjects, 
the distribution of urine albumin and 
creatinine concentrations was examined by 
using one ACR value (≥30 μg/mg) and sex-
specific cutpoints (≥17 μg/mg in men and ≥25 
μg/mg in women) measured in spot urine 
D 
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specimens.  Microalbuminuria (MAU) has 
been recognized as an independent and 
reliable predictor for future development of 
overt proteinuria in diabetic patients. It 
represents the condition in which minute 
quantities of albumin not detectable by simple 
urine dipstick are excreted into the urine. 
MAU is associated with a form of diabetic 
nephropathy that has a high morbidity and 
mortality as well as with coronary artery 
diseases. Furthermore, there have been many 
reports on the correlation of MAU with an 
increasing incidence of diabetic retinopathy. 
Therefore, MAU is an important biomarker 
for predicting complications of diabetic 
patients. In cases where high blood sugar 
control was successful, MAU also decreased.  
Microalbuminuria is an independent predictor 
of cardiovascular disease and all-cause 
mortality in both diabetic8 and nondiabetic 
men and women9, and may be a stronger 
indicator for future cardiovascular events than 
systolic BP (SBP) or serum cholesterol10. 
Detecting microalbuminuria is an important 
screening tool to identify people who are at 
high risk for cardiovascular events and the 
progression of kidney disease and who need 
more intensive therapy compared with 
subjects with normal albumin excretion 
rates11. According to the American Diabetes 
Association (ADA), the gold standard for 
measuring urine albumin excretion is a 24-h 
urine collection10. However, a more 
convenient method to detect 
microalbuminuria is the albumin 
(μg)/creatinine (mg) ratio (ACR) measured in 
a random urine specimen12. Currently, the 
National Kidney Foundation recommends the 
use of spot urine ACR obtained under 
standardized conditions (first voided, 
morning, midstream specimen) to detect 
microalbuminuria. The ACR is a more 
convenient test for patients and may be less 
prone to errors due to improper collection 
methods and variations in 24-h protein 
excretion compared with a random urine 
specimen13. 
The ADA and the National Kidney 
Foundation define microalbuminuria as an 
ACR between 30 to 300 μg/mg in both men 
and women10,11. These guidelines do not take 
into account sex differences in creatinine 
excretion, and several researchers have 
advocated sex-specific cutpoints of the ACR 
to define microalbuminuria12,13. However, no 
published studies have demonstrated how the 
use of a single ACR cut point versus sex-
specific ACR cut points measured in random 
urine samples affects the estimated 
prevalence of microalbuminuria in a 
nationally representative sample of United 
States subjects14. 
This descriptive cross-sectional study was 
carried to determine Microalbuminuria 
creatinine ratio, in long term Diabetic 
patients. 
MATERIAL AND METHODS: 
This study was descriptive analytical case 
control hospital based study. The study was 
carried out with fifty patients aged 35-55 
years who attended the Outpatient department 
of Omdurman teaching hospital, Medical 
Centre and Khartoum teaching hospital, 
Sudan from November 2011 to April 2012. 
All had type 2 diabetes mellitus diagnosed 
based on World Health Organization criteria. 
None had any apparent proteinuria with the 
dipstick test (Albustix, Boeringher Manheim, 
Manheim, Germany). All subjects were asked 
to supply their informed consent before the 
study. Subjects with long standing diabetes 
mellitus were regarded as test group and non-
diabetes persons were considered as control 
group. 
Sample size: 
Fifty urine samples from diabetic patients 
were collected randomly, for more than 10 
years and 50 samples from apparently healthy 
individuals as control. 
Inclusion criteria: 
Patients with long standing diabetes mellitus 
for more than 10 years were included in this 
study, while diabetic patients having blood 
glucose of less than 200 mg/dl at time of 
study were excluded.   
Microalbuminuria analysis:  
All urine samples were analyzed for micro-
albumin level by the immunoturbidimetric 
method using the Microalb kit. The 
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coefficient of variation (CV) is 7.0% at an 
albumin concentration of 21.4 mg/l and 5.5% 
at a concentration of 124 mg/l (normal value 
0-15 µg/minute; 0-20 mg/l). 2 ml of urine was 
used for the immunoturbidimetry test. The 
urine albumin concentrations were 
determined blindly by one of the authors. The 
reproducibility of the test was assessed by 
another author on 10 occasions for precision 
analysis. 
Estimation of creatinine by kinetic Jaffe 
method:  
Principle: The procedure is based upon the 
modification of the original picrate reaction 
(Jaffe). Creatinine under alkaline conditions 
reacts with picrate ions forming a yellowish 
complex.  
The formation rate of the complex is 
measured through the increase of absorbance 
in a prefixed interval of time which is 
proportional to the concentration of creatinine 
in the sample.  
 
→    






Permission to carry out this study was 
obtained from the ethical committee of the 
University of Medical Sciences and 
Technology, Khartoum, Sudan. 
The objectives of the study were explained to 
all individuals participating in this study. 
An informed consent was taken from both 
patients and control groups 
Data analysis: 
Statistical analysis was performed using 
statistical package for social science (SPSS) 
software version 12. Mean values of normally 
distributed continuous data were compared 
using student's t test. P value of 0.00 was 
considered significant at 95% confidence 
limit. 
RESULTS: 
The results of this study are presented in table 
(1) and figure (1). Microalbuminuria in 
Diabetic patients showed an increase when 
compared with the control group with P value 
0.000. Similarly creatinine also showed an 
increase in diabetic patients. 
 
Figure (1): Showing comparison between the 
mean of creatinine: albumin ratio in both 
healthy individuals and patients. 
DISCUSSION: 
The rates of albuminuria were very high in 
this large primary care population with type 2 
diabetes. One limitation of the study is that a 
single ACR result was used in this analysis, 
and the coefficient of variation of measures of 
albuminuria can be up to 20% 15. Although 
serial measures would increase precision, it is 
unlikely that they would move many 
individuals across categories of albuminuria 
or substantively change the findings. It has 
been suggested that ACR reference ranges 
should be adjusted by sex, age and race16-18, 
perhaps in relation to differences in muscle 
mass17,19. We are not aware of any validation 
studies of a single ACR compared to timed 
collections across our ethnic groups. We did 
not have a direct measure of renal function, 
such as serum creatinine, consistently 
available. It is likely that factors not measured 
in this study contribute to the association of 
albuminuria with ethnicity. A genetic 
predisposition to renal disease is possible, 
such as that found in African-Americans with 
non-diabetic renal disease20, but has yet to be 
demonstrated among other ethnic groups and 
for those with diabetes. Fetal programming 
with subtle dietary deficiencies, stress and 
high rates of smoking during pregnancy is 
considered to affect renal development in 
utero and may be associated with 
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hypertension, proteinuria and decreased renal 
function later in life21.  Differential access to 
health care, delayed diagnosis of diabetes and 
differential rates of medication prescription 
and adherence are all potential contributors to 
ethnic variations in albuminuria.  Low 
medication adherence among people with a 
long-term condition is a widespread 
problem22.   Poverty, itself recognized as 
having multiple relationships to renal disease 
and race or ethnicity23, is also associated with 
many of the factors we have described above.  
We determined the risk of nephropathy due to 
diabetes mellitus in Sudanese population.  
Our results indicated that the genetics of 
Sudanese race are more prone to 
microalbuminuria and thus to renal diseases.  
Therefore we observed a high ratio of 
albumin:creatinine ratio (112.1 g/mg) even in 
non-diabetes individuals and hence there is a 
very high albumin:creatinine ratio (464.4 
g/mg) in type 2 diabetes patients.  
Table (1): Showing comparison between the mean of creatinine / albumin ratio in both healthy 
individuals and patients.  
 
Table (2): Showing the correlation between the duration of diabetes mellitus and creatinine: 
albumin ratio in long term diabetic patients 
  Duration CrAlbR 
Duration Pearson Correlation 1 -0.092 
Sig. (2-tailed)  0.527 
N 50 50 
CrAlbR Pearson Correlation -0.092 1 
Sig. (2-tailed) 0.527  
N 50 50 
CONCLUSION: 
It is obvious from these results that, long 
standing diabetes mellitus decline the renal 
function, which was reflected as raised 
microalbuminuria:creatinine ratio. This in-
turn may lead to increased risk of developing 
renal failure. 
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